The global spirometer market is expected to post steady long-term growth, with its value rising from USD 1.35 billion in 2025 to USD 3.72 billion by 2035, according to an industry outlook from SNS Insider. The forecast points to sustained demand for lung-function testing tools as healthcare systems place more focus on earlier detection and ongoing monitoring of respiratory conditions.
Growth in the sector is being linked to broader respiratory disease screening and the increasing use of spirometry in routine clinical assessment. Spirometers are widely used to measure breathing performance, making them important in evaluating patients with chronic and acute pulmonary issues.
Regional projections in the report highlight strong expansion in the United States and Europe. The U.S. market is forecast to climb from USD 317.39 million in 2025 to USD 1.90 billion by 2035, while Europe is projected to grow from USD 376.92 million to USD 984.78 million over the same period.
Another major factor supporting the market outlook is the adoption of portable spirometers, which can broaden access to testing across clinics, outpatient settings and other care environments. As healthcare providers continue investing in respiratory diagnostics, demand for spirometry devices is expected to remain a key part of the wider pulmonary care market.
